Drugs / Moringa Oleifera
Moringa Oleifera
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05665985 | May → Jul 2020 | rheumatoid arthritis | Universitas Sebelas Maret | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT06125873 | Mar 2023 → May 2024 | type 2 diabetes mellitus | Islamabad Medical and Dental College | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04575948 | Dec 2027 → Nov 2028 expected | poisoning | Misr International University | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05623605 | Jun → Dec 2022 | dental caries | Nahda University | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT07337512 Comparator | May → Nov 2024 | postpartum depression | Melania Asi | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moringa oleifera | “Moringa Oleifera (MO) capsules, a herbal medicine,” NCT06125873 ↗ |
| Known as | Keloreena Ⓡ | “Intervention with Dry Extract of Moringa Oleifera (trade name is Keloreena Ⓡ , registered number in National Food and Drug Registry: 193332021) The dose given is 1000 mg bi in...” NCT05665985 ↗ |
| Known as | M. oleifera | “Moringa oleifera (M. oleifera) has been suggested as medication in the prevention or treatment of diabetes” PMID 32444043 ↗ Feb 2020 |
| Known as | ma-rum | “Moringa oleifera (MO or ma-rum in Thai) leaf has been widely used in T2DM patients.” PMID 27276742 ↗ Mar 2016 |
| Known as | Moringa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05623605 ↗ |